<ol class="cite-this-references"><li id="reference-A912">Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006 Jun 3;332(7553):1302-8. [<a href="/articles/A912" target="_blank">Article</a>] </li><li id="reference-A1195">Zhang J, Ding EL, Song Y: Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA. 2006 Oct 4;296(13):1619-32. Epub 2006 Sep 12. [<a href="/articles/A1195" target="_blank">Article</a>] </li><li id="reference-A178975">Brutzkus JC, Varacallo M: Naproxen . [<a href="/articles/A178975" target="_blank">Article</a>] </li><li id="reference-A178990">Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J: A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis. 2018 Feb 1;9(1):143-150. doi: 10.14336/AD.2017.0306. eCollection 2018 Feb. [<a href="/articles/A178990" target="_blank">Article</a>] </li><li id="reference-A179098">Todd PA, Clissold SP: Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs. 1990 Jul;40(1):91-137. doi: 10.2165/00003495-199040010-00006. [<a href="/articles/A179098" target="_blank">Article</a>] </li><li id="reference-A179110">Davies NM, Anderson KE: Clinical pharmacokinetics of naproxen. Clin Pharmacokinet. 1997 Apr;32(4):268-93. doi: 10.2165/00003088-199732040-00002. [<a href="/articles/A179110" target="_blank">Article</a>] </li><li id="reference-A179197">Falany CN, Strom P, Swedmark S: Sulphation of o-desmethylnaproxen and related compounds by human cytosolic sulfotransferases. Br J Clin Pharmacol. 2005 Dec;60(6):632-40. doi: 10.1111/j.1365-2125.2005.02506.x. [<a href="/articles/A179197" target="_blank">Article</a>] </li><li id="reference-A179191">Bowalgaha K, Elliot DJ, Mackenzie PI, Knights KM, Swedmark S, Miners JO: S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen. Br J Clin Pharmacol. 2005 Oct;60(4):423-33. doi: 10.1111/j.1365-2125.2005.02446.x. [<a href="/articles/A179191" target="_blank">Article</a>] </li><li id="reference-A38985">Tracy TS, Marra C, Wrighton SA, Gonzalez FJ, Korzekwa KR: Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation. Eur J Clin Pharmacol. 1997;52(4):293-8. [<a href="/articles/A38985" target="_blank">Article</a>] </li><li id="reference-A179224">Ruschitzka F, Borer JS, Krum H, Flammer AJ, Yeomans ND, Libby P, Luscher TF, Solomon DH, Husni ME, Graham DY, Davey DA, Wisniewski LM, Menon V, Fayyad R, Beckerman B, Iorga D, Lincoff AM, Nissen SE: Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur Heart J. 2017 Nov 21;38(44):3282-3292. doi: 10.1093/eurheartj/ehx508. [<a href="/articles/A179224" target="_blank">Article</a>] </li><li id="reference-A179227">Mellemkjaer L, Blot WJ, Sorensen HT, Thomassen L, McLaughlin JK, Nielsen GL, Olsen JH: Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol. 2002 Feb;53(2):173-81. doi: 10.1046/j.0306-5251.2001.01220.x. [<a href="/articles/A179227" target="_blank">Article</a>] </li><li id="reference-L6582">Naprelan FDA Label [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020353s034lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L6583">Naprosyn FDA Label [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017581s113,018164s063,020067s020lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L6595">Over-the-counter Medications in Pregnancy [<a href="https://www.aafp.org/afp/2003/0615/p2517.html" target="_blank">Link</a>] </li><li id="reference-L7309">Treximet FDA Label [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021926s013lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L7312">Vimovo FDA Label [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022511s023lbl.pdf" target="_blank">Link</a>] </li></ol>